# KLOW Peptide References — Full Citation List | KLOW Doctor

> Full citation list for KLOW peptide research: KPV, GHK-Cu, BPC-157, TB-500 and thymosin beta-4. DOIs and PubMed URLs indexed by component channel.

All citations used across this site. Organized by component channel. DOI and PubMed URL on each entry.

## Citation index

All references are to single-component studies. No controlled KLOW blend trial appears in this list — none has been published. Citations are numbered to match inline [N] markers across the site.

See full `references_index` at the bottom of this document.

## References

[1] Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. https://pubmed.ncbi.nlm.nih.gov/10469335/
[2] Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. https://pubmed.ncbi.nlm.nih.gov/14554208/
[3] Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. https://pubmed.ncbi.nlm.nih.gov/18061177/
[4] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
[5] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
[6] Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. https://pubmed.ncbi.nlm.nih.gov/40131143/
[7] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41966639/
[8] Philp D, et al. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 2004. https://pubmed.ncbi.nlm.nih.gov/14657002/
[9] Trachy RE, Fors TD, Pickart L, Uno H. The hair follicle-stimulating properties of peptide copper complexes. Results in C3H mice. Annals of the New York Academy of Sciences. 1991;642:468-469. https://pubmed.ncbi.nlm.nih.gov/1809108/
[10] Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. 2007;30(7):834-839. https://pubmed.ncbi.nlm.nih.gov/17703734/
[11] Fan C, Chen Y, Huang Q, et al. Overview of Short Peptides for Hair Loss. Biomedicines. 2026;14(4):864. https://pubmed.ncbi.nlm.nih.gov/42072405/
[12] Philp D, et al. Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci. 2007. https://pubmed.ncbi.nlm.nih.gov/17947589/
[13] Sosne G, et al. Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4. Front Immunol. 2024. https://pubmed.ncbi.nlm.nih.gov/39380984/
[14] Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Effect Following Intoxications. Pharmaceuticals (Basel). 2025;18(6):928. https://pubmed.ncbi.nlm.nih.gov/40573323/
[15] Zhang Y, et al. Tbeta4-exosome-loaded hemostatic and antibacterial hydrogel to improve vascularized wound repair. Mater Today Bio. 2025. https://doi.org/10.1016/j.mtbio.2025.101585

---

Four channels logged, each cited to its own study — a research console, not a clinic.